# Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy Volunteers

> **NCT03901313** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Treatment A - 400 mg Fasting
- **DRUG:** Treatment B - 400 mg Fed
- **DRUG:** Treatment C - 200 mg Fed

## Key facts

- **NCT ID:** NCT03901313
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2019-05-08
- **Final completion:** 2019-05-22
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03901313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03901313, "Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03901313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*